Overcoming Barriers to Diabetes Management in Young Adults with Type 1 Diabetes by Leveraging Telehealth: A Pilot Study
Endocrine Practice, ISSN: 1530-891X, Vol: 30, Issue: 2, Page: 135-140
2024
- 1Citations
- 18Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations1
- Citation Indexes1
- Captures18
- Readers18
- 18
- Mentions1
- News Mentions1
- 1
Most Recent News
Study Results from Harvard Medical School in the Area of Telemedicine Reported (Overcoming Barriers To Diabetes Management In Young Adults With Type 1 Diabetes By Leveraging Telehealth: a Pilot Study)
2024 MAR 26 (NewsRx) -- By a News Reporter-Staff News Editor at Ivy League Daily News -- Data detailed on Telemedicine have been presented. According
Article Description
The LIFT-YA (leveraging intensive follow-up treatment in young adults) quality improvement program was developed to address clinical and social barriers in young adults (YA) with type 1 diabetes (T1D), using telehealth visits to promote clinic attendance and improve diabetes care. LIFT-YA enrolled YA aged 18-30 with T1D and HbA1c >8% (64 mmol/mol) who had established adult care in our diabetes clinic. The 6-month, 7-visit hybrid program was facilitated by a case manager serving as the liaison between participants and the care team. The primary end-points were within-group and between-group changes from the baseline in HbA1c at the last visit and adoption of continuous glucose monitoring (CGM). Of the 57 eligible YA, 24 were enrolled and 33 were unable to participate (UTP). Thirteen of the enrolled participants attended at least 4/7 visits (“completers”, C), whereas 11 were noncompleters (NC). HbA1c at the end of the program was significantly lower in the C versus UTP group [median −1.0; IQR (−0.6, −2.5) vs −0.25 (0.2, −1.0) in UTP; P <.05]. The percentage of CGM users significantly increased by 70% in the C group ( P <.05), but did not change in the NC and UTP groups. Limited access to telehealth and the high cost of frequent visits were the main hurdles preventing enrollment into or completion of the program. The LIFT-YA pathway was associated with a significant HbA1c reduction and an increase in the adoption of CGM. Policy changes are necessary to expand access to LIFT-YA and other programs for high-risk YA with T1D in underserved communities and across all backgrounds.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1530891X23007565; http://dx.doi.org/10.1016/j.eprac.2023.11.005; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85180776734&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/38008258; https://linkinghub.elsevier.com/retrieve/pii/S1530891X23007565; https://dx.doi.org/10.1016/j.eprac.2023.11.005
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know